arrow
D

Daniel Reim

technical university of munich
H指数:34
被引数:4,480

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Standard reporting on duodenal stump leakage after gastric cancer resections: multicentre analysis from the GASTRODATA Study Group (the STARDUST study)

胃癌切除术后十二指肠残端漏的标准报告:GASTRODATA研究小组(STARDUST研究)的多中心分析

2026-09-010
PRE
Comparison of Pretreatment Strategies for cT2cN0 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A European High-Volume Center Cohort Analysis

cT2cN0期食管和胃食管结合部腺癌的术前治疗策略比较:一项欧洲高容量中心队列分析

2025-10-130
OA
ASO Visual Abstract: Staging Laparoscopy in Patients with Gastric Cancer Treated with Curative Intent—A European GASTRODATA Cohort Study

ASO可视化摘要:接受治愈性治疗意向的胃癌患者分期腹腔镜手术——一项欧洲GASTRODATA队列研究

2025-09-010
PRE
Staging Laparoscopy in Gastric Cancer Patients Treated with Curative Intent: A European GASTRODATA Cohort Study

以治愈为目的治疗的胃癌患者分期腹腔镜检查:一项欧洲GASTRODATA队列研究

2025-07-260
OA
Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysis

预后营养指数对晚期胃癌患者肿瘤学结局和死亡率的影响:欧洲GASTRODATA登记研究分析

2025-05-280
PRE
Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective Cohort Analysis
2024-08-070
PRE
Intraoperative Wound Irrigation for the Prevention of Surgical Site Infection After Laparotomy
2024-05-018
OAAI
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification (vol 14, 4632, 2023)

蛋白质基因组分析揭示RNA作为肿瘤无关的新抗原鉴定的来源 (第14卷,4632,2023)

2024-03-150
OAAI
Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement vs. primary suture only in midline laparotomies (PRIMA): long-term outcomes of a multicentre, double-blind, randomised controlled trial
2024-01-016
OA
Textbook Oncological Outcome in European GASTRODATA
2023-08-0915
PRE
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
2023-08-0216
OAAI
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III PREVENT-(FLOT9) trial of the AIO/CAOGI /ACO
2021-10-2929
OAAI
The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)
2021-09-0132
OAAI